[Allergies to 8-hydroxyquinoline derivatives].
Evaluation of our standardized test results from 1972 to 1983 indicated Vioform allergies in 1.2% of all cases and Sterosan allergies in 1.1%. Our results are within the spectrum found in the literature for Vioform between 0.3 and 5.1% and for Sterosan between 0.3 and 3.7%. In the course of those 12 years we observed a growing tendency towards Vioform and Sterosan allergies on the basis of annual percentage figures. In the last year of our observation the frequency of Vioform and Sterosan allergies amounted to 1.7% each. We conclude, therefore, that inclusion of these two substances in the standard battery is justified. According to the pertinent literature, Sterosan and Vioform allergies are, on an average, 3 to 4 times more frequent in patients suffering from leg ulcers and/or chronic venous insufficiency than amongst eczema patients.
Hutzler
D
D
Dermatologischen Klinik und Poliklinik, Universität Würzburg.
Pevny
I
I
D002750:Chlorquinaldol / Q000009:adverse effects; D007464:Clioquinol / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines / Q000009:adverse effects*; D008297:Male; D015125:Oxyquinoline / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D010328:Patch Tests; D014689:Venous Insufficiency / Q000188:drug therapy*
D006912:Hydroxyquinolines; D015125:Oxyquinoline; D007464:Clioquinol; D002750:Chlorquinaldol
Allergien gegen 8-Hydroxychinolin-Derivate.